Life Science News

25 April 2007 - AstraZeneca acquires MedImmune adding to its biologics and vaccines projects

$15.6bn cash deal to create a fully integrated biopharmaceuticals business AstraZeneca (AZ) has acquired MedImmune, Inc. in a cash deal worth $15.6..  More >>

15 April 2007 - The Blackstone Group completes Cardinal PTS acquisition for $3.3bn

Cardinal Health has completed the sale of its Pharmaceutical Technologies and Services (PTS) business to The Blackstone Group for about $3.3 billion...  More >>

11 March 2007 - Manon Cox of Protein Sciences Corp reviews biopharma options for influenza pandemic preparedness at Bio/PharMOS 2007

Fresh business opportunities for outsourcing services central to the conference agenda from collaboration, deals and alliances in a true spirit..  More >>

10 March 2007 - Patheon reports healthy Q1 revenue growth from development & manufacturing services

Company in good shape and poised to move forward with new financial partner. Mississauga, Ontario based Patheon has reported its Q1 revenues: Q1 Revenues:..  More >>

07 March 2007 - Eisai chooses UK for pharma manufacturing base in Europe

Eisai Co., Ltd. has selected Hatfield, UK, as the location to establish its first European pharmaceutical manufacturing operation. The..  More >>

22 February 2007 - Bionest Partners opens another door for life science investment

Bionest Partners, strategy and advisory specialist in the healthcare sector of the Life Science industry, wins an exclusive mandate from the Solidarity Fund..  More >>

12 February 2007 - Boehringer & Laureate strike transatlantic biomanufacturing deal

Laureate Pharma gets access to Boehringer Ingelheim's technology for biologics production. Boehringer Ingelheim (BI) has signed a preferred..  More >>

09 February 2007 - GSK moves closer to flu pandemic preparedness with European filing

The European Committee for Medicinal Products for Human Use (CHMP) has accepted GlaxoSmithKline's new generation H5N1 split antigen pre-pandemic flu..  More >>

02 February 2007 - 10,000 jobs to be shed at Pfizer

Pfizer restructuring will lead to 10,000 layoffs by 2008 Pfizer's chairman and chief executive officer Jeffrey B. Kindler announced plans to shake up the..  More >>

18 March 2006 - Risk Management: NextPharma's CEO opens Bio/PharMOS 2006 Masterclass

Opening the business Masterclass session at this year's annual Bio/PharMOS & Bio/PharDOS event for the contract services sector, Bill Wedlake, CEO of..  More >>

13 March 2006 - Medac's boss to lead Monaco March Masterclass.

Dr Rainer Uhlenbusch (pictured) 'gets to the heart of the matter' supported by a professional line-up of keynote speakers and panellists at the..  More >>

28 February 2006 - MorphoSys - strategy product development updated

New lead compound, MOR103, to go into the clinical development process for rheumatoid arthritis. MorphoSys AG has decided to focus its development..  More >>